Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EAE vaccine hit by supply issues
"We encourage all farmers to consult their vet and explore alternative means of safeguarding the health of their flocks during this period" – Rory Geary.

Shortages are expected to last for two to three weeks.

Ceva Animal Health has announced that there will be supply issues towards the end of the main vaccination season with the Cevac Chlamydia vaccine, which protects sheep against enzootic abortion of ewes (EAE).

The shortage, which is predicted to last for two to three weeks, is being blamed on delays in the manufacturing and distribution process.


Supply issues had been expected. Back in March, Ceva warned about potential shortages, urging farmers to make sure that their ewes were vaccinated early to avoid being affected by supply problems later in the year.


Ceva has said that the problem is expected to be temporary and it will be taking steps to minimise the impact on customers.

Rory Geary, Ceva Animal Health’s regional director for Northern Europe, said: “In collaboration with relevant stakeholders, we have implemented comprehensive contingency plans to optimise the manufacturing and distribution process.

"Our dedicated team is working closely with our partners to resolve the challenges and restore normal supply levels as soon as possible. The vaccine challenge is being treated with the utmost urgency, and we are actively exploring alternative sourcing options to supplement the existing supply chain.”

EAE is one of the most commonly diagnosed causes of abortion in ewes, with the cost to the UK sheep industry estimated to be up to £20 million a year.

Farmers who are unable to vaccinate their sheep due to the shortage are being encouraged to speak to their veterinary surgeon.

Mr Geary added: “We anticipate that the delay in supply will be resolved in the near future, however we recognise that for some farmers the supply will arrive too late for them to use.

"We encourage all farmers to consult their vet and explore alternative means of safeguarding the health of their flocks during this period. We recommend implementing robust biosecurity measures and adhering to existing vaccination protocols for other preventable diseases to ensure the overall wellbeing of livestock.

“We will provide vet practices and the wider industry with regular updates as we progress toward a resolution and return to normal supply levels.”

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.